Grand Journal of Urology
E-ISSN : 2757-7163

Robot-Assisted Radical Prostatectomy in Patients with Enlarged Median Lobe: Matched Analysis
Taner Kargi1, Kamil Gokhan Seker2, Abdullah Hizir Yavuzsan3, Buğra Dogukan Torer4, Muhammed Yusuf Demir1, Deniz Noyan Ozlu1, Serdar Karadag1, Selcuk Sahin1, Volkan Tugcu2, Ali Ihsan Tasci1
1Department of Urology, University of Health Sciences, Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey
2Department of Urology, Liv Hospital Vadistanbul, Istanbul, Turkey
3Department of Urology, University of Health Sciences, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey
4Department of Urology, Reyhanlı State Hospital, Hatay, Turkey
DOI : 10.5505/GJU.2022.68077
Pages : 064-071


Objective: Evaluation of surgical, oncological and functional results in patients with prostate cancer and enlarged median lobe who underwent robot- assisted radical prostatectomy (RARP).

Materials and Methods: Medical records of 489 patients who underwent RARP between August 2009 and December 2013 were retrospectively evaluated. Among them, 40 patients who had enlarged median lobe were included in Group 1. Forty patients without median lobe hyperplasia were included with matched analysis (Group 2). Patients who were followed up for 12 months were assessed.

Results: No significant differences were found between the two groups in terms of demographic values, erectile function, preoperative PSA levels, prostate dimensions, distribution of clinical stages, Gleason scores and D"Amico risk classification (p˃0,05). Perioperative data revealed that mean operative times were 219.9 ± 64.5 (130-360) min and 185.6 ± 57.1 (120-355) min in Groups 1 and 2, respectively which was significantly prolonged in Group 1 (p˂0.05). Bladder neck reconstruction was performed in Groups 1 (n=14: 5%) and 2 (n=1: 3%). Rates of full continence after removal of urethral catheter on day 7 and at the end of months 1, 3, 6 and 12 were similar in Groups 1 and 2 (p˃0.05). Rates of potency and biochemical recurrence were similar at the end of the postoperative 6 months and one year in Groups 1 and 2 (p˃0.05).

Conclusion: RARP in patients with prostate cancer with an enlarged median lobe is a challenging operation with significantly longer operative times. With its inherent procedural difficulties, RARP is a good treatment option in patients with prostate cancer and an enlarged median lobe with its successful surgical dissection and anastomosis possibilities.


Radical prostatectomy (RP) is the gold standard treatment option in cases with organ limited prostate cancer (PCa) with a life expectancy of more than 10 years. Primary goal of the operation is complete removal of the tumor. However, it is very important that the patient maintains its postoperative erectile function and urinary continence [1]. Although the oncological results are positive, there is an increasing interest in minimally invasive methods due to the higher perioperative complication rates of open surgery and the negative consequences of postoperative functional outcomes such as erectile dysfunction and incontinence [2]. However, there are randomized controlled studies showing that the functional results are similar [3].

Laparoscopic radical prostatectomy has not been widely used due to its technical difficulties and long learning curve [4]. It was possible to overcome the challenges of the complex laparoscopic method when Da Vinci robotic system was introduced in that it enhanced movement ability of the operator"s wrist, eliminated hand tremors of the surgeon, enabled more sensitive work in a three-dimensional medium with greater possibility of successful surgical dissection and anastomosis [5,6].

Large prostates cause difficulties in treatment. Large prostates restrict mobilization in the pelvis and may distort the visual appearance [7]. However, the stereoscopic visualization, magnification, and improved ergonomics of robot-assisted radical prostatectomy (RARP) can reduce the challenges posed by enlarged prostates with hyperplasic median lobes. However, RARP was found to be associated with more bleeding and longer operative times in some studies performed in patients with a large prostate and especially a voluminous median lobe, although functional and oncological results were not significantly different [7-10].

The aim of this cross-sectional study is to evaluate the effect of the enlarged median lobe on the surgical, oncological and functional outcomes of RARP in patients with enlarged median lobe and PCa in our patient series.

Materials and Methods

Local ethics committee approval was obtained prior to study (Dr. Sadi Konuk Training and Research Hospital Ethics Committee approval number: 2015/247). Medical records of 489 patients who underwent RARP between August 2009 and December 2013 were retrospectively evaluated. Among 489 patients aged between 47 and 78 years who had not undergone prior prostate surgery (transurethral resection of the prostate [TUR-P], transvesical prostatectomy [TVP]) and abdominal surgery were included in the study. Patients included in the study in both groups were operated through an intraperitoneal posterior approach by the same surgeon (A.I.T.). Since achievement of 150 cases of RARP was accepted as the criterion for the completion of the learning curve in the literature [11], we also excluded the first 150 patients to eliminate the effect of the learning curve. After inclusion and exclusion criteria were applied, the first 40 patients with, large median lobes were chronologically classified as Group 1, and the first 40 patients without as Group 2, according to the time of operation.

Preoperative parameters of the patients (age, body mass index [BMI], preoperative prostate-specific antigen [PSA] level, clinical stage, biopsy Gleason score, International Prostate Symptom Score [IPSS], prostate dimensions, risk groups according to D"Amico risk classification and American Society of Anesthesiologists [ASA] scores were recorded. Since our patient series started in 2009, multiparametric magnetic resonance imaging (mpMRI) of the prostate could not be used in many patients. Therefore, preoperative transrectal ultrasonography (TRUS) measurements were used as a reference to ensure homogeneity in prostate volume measurements. Since the dimensions of the median lobe are important during the operation, size of the median lobe was measured separately during the measurement of the prostate dimensions. Prostate cancer patients with an enlarged median lobe of the prostate with its largest diameter greater than 1 cm were accepted as having prostate cancer with a large median lobe.

Amount of perioperative blood loss, total duration of operation, robotic docking, and operative console times, duration of the anastomosis procedures, whether or not a nerve sparing technique was used, requirement for bladder neck reconstruction, postoperative hospital stay, dwell time of urethral catheter, pathological stage, Gleason score and surgical margin positivity were recorded for all RARP cases. Perioperative and postoperative complications were evaluated using modified Clavien classification [12].

Preoperative evaluation demonstrated that all patients included in the study were fullly continent. Functional results associated with urinary incontinence were evaluated after postoperative removal of urethral catheters on day 7 and at the end of the 1., 3., 6., and 12. months for the first postoperative year. Complete urinary continence was defined as no need to use pads or lack of urinary leakage. Daily requirement for one pad (safety pad) was considered as mild incontinence (stress incontinence) and use of more than one pad as incontinence.

Prior to RARP, each patient responded to five items of The International Index of Erectile Function (IIEF-5) questionnaire to evaluate their potency. Evaluation of erectile function was performed in postoperative 6 and 12 months. Potency was defined as rigid erection required for penetration. Individuals with a score of greater than 17 were accepted as having a normal potency [13].

Surgical Technique
All RARP operations were performed using the Frankfurt technique defined by Wolfram et al. [14]. Some technical modifications were applied during the stages of RARP operation in patients with an enlarged median lobe. For example, the margin of bladder neck and prostate was dissected transversely by the aid of a monopolar cautery. When an indented median lobe was encountered at this stage upon entrance into the bladder, the indented part was hung using a 2/0 vicryl suture or by the help of a grasper that was the fourth arm of the robot and dissection was started with its aid. During the anastomosis, bladder reconstruction was performed in the shape of an inverse racquet in patients with an enlarged median lobe. In patients in whom bladder neck reconstruction was required, the large base of the racquet was completed with bilateral continuous sutures applied on the bladder neck up to the 12 o"clock level, starting the anastomosis from 6 o"clock level using side- to- side and outside-in suturing techniques. Subsequently, the sutures were crossed reciprocally, and continuous sutures were applied until the defect on the bladder was closed and thus the handle of the racquet was created (Figure 1). None of the patients required ureteral stent placement to protect the ureteral orifices.

Figure 1: Bladder neck and median lobe (a). Bilobar median lobe (b). Wide open bladder neck (c). Bladder neck reconstruction reverse racket movement (d).

Statistical analysis
Mean, standard deviation, median, lowest, highest, frequency and percent values were used in the descriptive statistics of the data. Distribution of the variables was measured using Kolmogorov-Smirnov test. Mann-Whitney U test and independent samples t-test were used in the analysis of quantitative data. Chi-square test and Fisher's exact test were used in the analysis of the qualitative data where appropriate. The p<0.05 was accepted as statistically significant. SPSS 22.0 program was used in the analysis.


Preoperative clinicopathological specifications of the two groups such as age of the patients, BMI, preoperative PSA level, prostate dimensions, clinical stage, Gleason scores, ASA scores, D"Amico classification and preoperative potency and continence status were comparable. Percent of patients with higher preoperative IPSS scores was significantly greater in Group 1 compared to Group 2 (p˂0.05) (Table 1).

Table 1: Patient demographic characteristics

Mean duration of operation, operative console times and duration of urethrovesical anastomosis (UV) anastomosis was found to be significantly longer in Group 1 compared to Group 2 (p˂0.05). Amount of mean perioperative bleeding, duration of catheterization and hospital stay were similar in both groups (p˃0.05). Data of perioperative findings are demonstrated in Table 2.

Table 2: Perioperative and postoperative data

No significant differences were found in the rates of using nerve preserving technique, positive surgical margin, Gleason score distribution of the specimen and biochemical recurrence rates between Groups 1 and 2 (p˃0,05). Bladder neck reconstruction was performed in 14 (35%) patients in Group 1 and 1 patient (3%) in Group 2. Rate of bladder neck reconstruction was significantly higher in Group 1 compared to Group 2 (p˂0.05) (Table 3).

Table 3: Perioperative technique and postoperative oncological data

Anastomotic leak was detected in 3, urinary system infection in 1, bleeding requiring blood transfusion in 1, pulmonary embolus necessitating intensive care stay in 1 and urethral stenosis during follow-up in 3 patients in Group 1. On the other hand, anastomotic leak was found in 1, ileus resolving by conservative treatment in 2, and bleeding requiring blood transfusion in 1 patient in Group 2. Complications are demonstrated in Table 4.

Table 4: Complication rates

Results of postoperative functional evaluation are demonstrated in Table 5. Rates of complete urinary continence was similar in both groups following removal of urethral catheters on postoperative day 7, months 1, 3, 6 and 12 (p˃0.05). No significant differences were found in the rates of potency in the postoperative 6th month and 1st year between Groups 1 and 2 (p˃0,05).

Table 5: Functional outcomes


Widespread use of medical treatment in benign prostatic hyperplasia (BPH) results in postponed surgical treatment and encountering patients diagnosed with clinically localized prostate cancer detected during PSA screening tests and enlarged prostates [15]. Due to the increasing popularity of active observation, the dimensions of the prostate may increase during the follow-up period, and the necessity of performing curative treatment of the prostate with larger dimensions arises. Radical prostatectomy has become the emerging curative treatment in patients with a large prostate due to the limitations of radiotherapy and brachytherapy in patients with greatly enlarged prostates [16,17]. Challenges of RARP operation in patients with a large prostate and especially with an enlarged median lobe have been scrutinized in many studies and the results of the studies have been published [7-10].

Operative time is a significant perioperative parameter. Considering the Trendelenburg position of the patients during the operation, prolonged surgeries may carry life-threatening risks. The mean duration of operation was significantly longer in patients with an enlarged median lobe compared to those without (219.9 ± 64.5 minutes vs 185.6 ± 57.1 minutes). In their study, Huang et al., emphasized that the greatly enlarged median lobe significantly lengthened the duration of operation when compared to those without (185.8 ± 65.8 minutes vs 155.0 ± 40.8 minutes) [18]. Similarly, Meeks et al. found that the mean duration of operation was significantly longer in BPH patients an enlarged median lobe compared to those without (349 and 287 minutes, respectively) [19]. The authors stated that the causes longer operative times were difficulty encountered in the posterior dissection of the prostate and dissection of vesicula seminalis in patients with an enlarged median lobe. Freeing the vesicula seminalis using intraperitoneal posterior approach through the Douglas space resolved this problem in the present study. The authors reported that another and the most significant cause was that the defect was larger than normal during the bladder neck opening in patients with an enlarged median lobe and stated that 40% of those patients required bladder neck reconstruction. In another study Link et al., stated that patients with larger prostates frequently had an enlarged median lobe, and this condition caused a larger opening in the bladder neck during the dissection of the prostate from inside the bladder. They emphasized that the requirement of bladder neck reconstruction was thus increased, and the operation was lengthened during the stage of vesicourethral anastomosis [10]. In the present study, we also found that 35% of the patients with an enlarged median lobe required bladder neck reconstruction which lengthened the duration of vesicoureteral anastomosis and operation.

Another important parameter of the RARP operation is perioperative bleeding. Huang et al. reported the mean perioperative amount of bleeding as 236.4 ± 99.9 ml and 193.3 ± 93.1 ml in patients with and without enlarged median lobe, respectively [18]. Similarly, Meeks et al. found a significantly increased amount of bleeding in patients with an enlarged median lobe (464 ml and 380 ml) [19]. In this present study, on the other hand, no statistically significant difference was found in the mean perioperative amount of bleeding between the two groups. Similar to our study, Hamidi et al., reported no significant effect of the presence of the enlarged median lobe on the amount of bleeding compared to those without (285 ml vs 280 ml) [20].

Meeks et al. evaluated postoperative bladder neck stenosis in patients with an enlarged median lobe who underwent RARP, and found that the incidence of bladder neck stenosis (7% vs 4%) and urinary incontinence (22% vs 15%) was higher compared to patients with normal prostate anatomy, though without any statistically significant difference between them [19]. Similarly, in this study any statistically significant differences were not found between the two groups in terms of the incidence of postoperative bladder neck stenosis and urinary incontinence.

Positive surgical margin (PSM) following RARP is one of the independent factors affecting biochemical recurrence and development of local recurrence and metastasis [21]. In the present study, the rate of positive surgical margin was 10%, in both groups, similar to the literature data [22,23]. Similar to our study, many authors reported that the presence of an enlarged median lobe had no effect on the surgical margin positivity following RARP [18,19].

Although the primary aim of radical prostatectomy is complete excision of the tumor, the maintenance of postoperative erectile function and urinary continence are of utmost importance. Preservation of neurovascular bundle (NVB) during radical prostatectomy is not only effective in the maintenance of erectile function, but also in the recovery of the urinary functions. Comparative studies demonstrated a complete continence rate of 70-81% in patients who did not undergo NVB sparing RP, while higher continence rates such as 90-94% were seen following nerve preserving surgery with a statistically significant difference between the two techniques [24,25]. The rates of complete continence in the present study are similar to the those reported in the literature. Among the authors evaluating the effect of prostate volume on continence, Huang et al. reported that dimensions of the prostate had no effect on the recovery of urinary functions following RARP [18]. Meek et al. found no significant difference in general continence rates between BPH patients with and without an enlarged median lobe [19]. Contrarily, some authors emphasized that prostate volume affected continence rates and large prostate volume negatively affected the continence rate [26]. In our study, no significant difference was found in incontinence rates at 6th and 12th months after RARP when patients with and without enlarged median lobes were compared.

Preservation of potency is important and possible after radical prostatectomy. Age, using a NVB sparing surgical technique, preoperative state of potency, and some chronic diseases are conditions affecting postoperative erectile function. Age is especially one of the most important factors affecting the severity of erectile dysfunction (ED) that develops following RP [27]. Young patients report a low rate of ED postoperatively and the rate of recovery of erection has been reported to be 92% following RP in patients between the ages of 40 and 49 years [28]. Catalona et al. reported that potency was preserved at rates of 68% and 47% during postoperative follow-up after RP in cases with bilateral and unilateral preservation of NVB, respectively [29]. On the other hand, some authors evaluated the effects of prostate dimensions on post-RP potency and found no significant difference [30]. Huang et al. also reported that the size of the prostate did not effect the post-RARP erectile function [18]. In this study, we evaluated the effect of an enlarged median lobe on potency after RARP and found no significant difference between the groups with and without enlarged median lobes in terms of potency rates at postoperative 12th-month.

One of the limitations of this present study is its retrospective nature. The second limitation is the low number of patients. In addition, as another limiting factor the surgeries were performed by a surgeon who had completed his learning curve, thus the results of RARPs conducted by a surgeon who hasn't completed the learning curve are not known.


RARP in prostate cancer patients with an enlarged median lobe is a difficult procedure with significantly longer operative times. For this reason, preoperative USG should be planned for patients who are scheduled for RARP and the median lobe should be evaluated. Considering our study results, no significant difference was found between the groups with and without enlarged median lobes in terms of clinical and functional results, except for the duration of the operation. This finding reveals us that although RARP is a challenging procedure, it is a good treatment option in prostate cancer patients with an enlarged median lobe.

Ethics Committee Approval: The study was approved by the Ethics Committee of University of Health Sciences, Dr. Sadi Konuk Training and Research Hospital (Approval date, and registration number: 07.12.2015/247).

Informed Consent: An informed consent was obtained from all the patients.

Publication: The results of the study were not published in full or in part in form of abstracts.

Peer-review: Externally peer-reviewed.

Authorship Contributions: Any contribution was not made by any individual not listed as an author. Concept – T.K., K.G.S., V.T., A.I.T.; Design – T.K., B.D.T.; Supervision – S.S., V.T, A.I.T.; Resources – B.D.T., M.Y.D.; Materials – D.N.O., M.Y.D.; Data Collection and/or Processing – K.G.S., A.H.Y., D.N.O., S.K.; Analysis and/or Interpretation – T.K., D.N.O., S.S.; Literature Search – K.G.S., A.H.Y., V.T.; Writing Manuscript – D.N.O., S.K., A.I.T.; Critical Review – T.K., A.H.Y., B.D.T., V.T., A.I.T.

Conflict of Interest: All authors have no conflict of interest.

Financial Disclosure: The authors declared that this study has received no financial support.


1) Partin AW, Mangold LA, Lamm DM, Walsh PC, Epstein JI, Pearson JD. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 2001;58:843-8.

2) Walsh PC, Donker PJ. Impotence following radical prostatectomy: insight into etiology and prevention. J Urol 2017;197:S165-S70.

3) Coughlin GD, Yaxley JW, Chambers SK, Occhipinti S, Samaratunga H, Zajdlewicz L, et al. Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study Lancet Oncol 2018;19:1051-60.

4) Schuessler WW, Schulam PG, Clayman RV, Kavoussi LR. Laparoscopic radical prostatectomy: initial short-term experience. Urology 1997;50:854-7.

5) Thompson J. Myocardial infarction and subsequent death in a patient undergoing robotic prostatectomy. AANA J 2009;77:365-71.

6) Mehta Y, Arora D, Sharma KK, Mishra Y, Wasir H, Trehan N. Comparison of continuous thoracic epidural and paravertebral block for postoperative analgesia after robotic-assisted coronary artery bypass surgery. Ann Card Anaesth 2008;11:91-6.

7) Chan RC, Barocas DA, Chang SS, Herrell SD, Clark PE, Baumgartner R, et al. Effect of a large prostate gland on open and robotically assisted laparoscopic radical prostatectomy. BJU Int 2008;101:1140-4.

8) Zorn KC, Orvieto MA, Mikhail AA, Gofrit ON, Lin S, Schaeffer AJ, et al. Effect of prostate weight on operative and postoperative outcomes of robotic-assisted laparoscopic prostatectomy. Urology 2007;69:300-5.

9) Skolarus TA, Hedgepeth RC, Zhang Y, Weizer AZ, Montgomery JS, Miller DC, et al. Does robotic technology mitigate the challenges of large prostate size? Urology 2010;76:1117-21.

10) Link BA, Nelson R, Josephson DY, Yoshida JS, Crocitto LE, Kawachi MH, et al. The impact of prostate gland weight in robot assisted laparoscopic radical prostatectomy. J Urol 2008;180:928-32.

11) Ou YC, Yang CR, Wang J, Yang CK, Cheng CL, Patel VR, et al. The learning curve for reducing complications of robotic-assisted laparoscopic radical prostatectomy by a single surgeon. BJU Int 2011;108:420-5.

12) Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205-13.

13) Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999;11:319-26.

14) Wolfram M, Bräutigam R, Engl T, Bentas W, Heitkamp S, Ostwald M, et al. Robotic-assisted laparoscopic radical prostatectomy: the Frankfurt technique. World J Urol 2003;21:128-32.

15) Feneley MR, Landis P, Simon I, Metter EJ, Morrell CH, Carter HB, et al. Today men with prostate cancer have larger prostates. Urology 2000;56:839-42.

16) Zelefsky MJ, Ginor RX, Fuks Z, Leibel SA. Efficacy of selective alpha-1 blocker therapy in the treatment of acute urinary symptoms during radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 1999;45:567-70.

17) Crook J, McLean M, Catton C, Yeung I, Tsihlias J, Pintilie M. Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation. Int J Radiat Oncol Biol Phys 2002;52:453-60.

18) Huang AC, Kowalczyk KJ, Hevelone ND, Lipsitz SR, Yu HY, Plaster BA, et al. The impact of prostate size, median lobe, and prior benign prostatic hyperplasia intervention on robot-assisted laparoscopic prostatectomy: technique and outcomes Eur Urol 2011;59:595-603.

19) Meeks JJ, Zhao L, Greco KA, Macejko A, Nadler RB. Impact of prostate median lobe anatomy on robotic-assisted laparoscopic prostatectomy. Urology 2009;73:323-7.

20) Hamidi N, Atmaca AF, Canda AE, Keske M, Gok B, Koc E, et al. Does presence of a median lobe affect perioperative complications, oncological outcomes and urinary continence following robotic-assisted radical prostatectomy? Urol J 2018;15:248-55

21) Pfitzenmaier J, Pahernik S, Tremmel T, Haferkamp A, Buse S, Hohenfellner M. Positive surgical margins after radical prostatectomy: do they have an impact on biochemical or clinical progression? BJU Int 2008;102:1413-8.

22) Jr Smith JA, Chan RC, Chang SS, Herrell SD, Clark PE, Baumgartner R, et al. A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy. J Urol 2007;178: 2385-9.

23) Patel VR, Thaly R, Shah K. Robotic radical prostatectomy: outcomes of 500 cases. BJU Int 2007;99: 1109-12.

24) Twiss C, Fleischmann N, Nitti VW. Correlation of Abdominal Leak Point Pressure with Objective Incontinence Severity in Men with Post-Radical Prostatectomy Stress Incontinence. Neurourol Urodyn 2005;24:207-10.

25) Tiguert R, Gheiler EL, Gudziak MR. Collagen Injection in the Management of Post-radical Prostatectomy Intrinsic Sphincteric Deficiency. Neurourol Urodyn 1999;18:653-8.<653::aidnau16>;2-l

26) Konety BR, Sadetsky N, Carroll PR, CaPSURE Investigators. Recovery of urinary continence following radical prostatectomy: the impact of prostate volume analysis of data from the CaPSURE database. J Urol 2007;177:1423-5

27) Kumar A, Samavedi S, Bates AS, Cuevas CAG, Coelho RF, Rocco B, et al. Age stratified comparative analysis of perioperative, functional and oncologic outcomes in patients after robot assisted radical prostatectomy-A propensity score matched study. Eur J Surg Oncol 2015;41:837-43.

28) Kundu SD, Roehl KA, Eggener SE, Antenor JAV, Han M, Catalona WJ. Potency, continence and complications in 3,477 consecutive radical retropubic prostatectomies. J Urol 2004;172:2227-31.

29) Catalona WJ, Smith DS. Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: intermediate-term results. J Urol 1998;160:2428-34.

30) Chang CM, Moon D, Gianduzzo TR, Eden CG. The impact of prostate size in laparoscopic radical prostatectomy. Eur Urol 2005;48:285-90.

Keywords : median lobe, prostate cancer, robot-assisted radical prostatectomy

Viewed : 2094
Downloaded : 540